Comparing 7 vendors in Microfluidics across 0 criteria.
Become a Client
- Access Exclusive Reports, expert insights and tailored support to drive growth.
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
2.1 DRIVERS
2.1.1 Growing requirement for point-of-care testing
2.1.2 Rising technological advancements
2.1.3 Increasing focus on data precision and accuracy
2.1.4 Economic benefits associated with microfluidics
2.1.5 Portability with microfluidic chip miniaturization
2.1.6 Rising demand for effective sample analysis
2.2 RESTRAINTS
2.2.1 Stringent regulatory approval process
2.2.2 Integration of microfluidics into current workflow
2.2.3 OPPORTUNITIES
2.2.4 Emergence of 3D cell culture systems
2.2.5 Growth potential of emerging economies
2.2.6 Use of microfluidics in life sciences & pharmaceutical industries
2.3 CHALLENGES
2.3.1 Low adoption of microfluidic devices among end users
3.1 INTRODUCTION
3.2 KEY PLAYER STRATEGY/RIGHT TO WIN
3.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET
3.4 REVENUE ANALYSIS
3.5 MARKET SHARE ANALYSIS BY KEY PLAYERS,2023
3.6 RANKING OF KEY MARKET PLAYERS
3.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
3.7.1 STARS
3.7.2 EMERGING LEADERS
3.7.3 PERVASIVE PLAYERS
3.7.4 PARTICIPANTS
3.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
3.7.5.1 Company footprint
3.7.5.2 Product footprint
3.7.5.3 Application footprint
3.7.5.4 End-user footprint
3.7.5.5 Region footprint
3.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
3.9 COMPETITIVE SCENARIO
3.9.1 PRODUCT LAUNCHES & APPROVALS
3.9.2 DEALS
3.9.3 EXPANSIONS
3.9.4 OTHER DEVELOPMENTS
4.1 KEY PLAYERS
4.1.1 DANAHER CORPORATION
4.1.1.1 Business overview
4.1.1.2 Products offered
4.1.1.3 Recent developments
4.1.1.3.1 Product launches
4.1.1.3.2 Deals
4.1.1.4 MnM view
4.1.1.4.1 Key strengths
4.1.1.4.2 Strategic choices
4.1.1.4.3 Weaknesses and competitive threats
4.2.1 ILLUMINA, INC.
4.2.1.1 Business overview
4.2.1.2 Products offered
4.2.1.3 Recent developments
4.2.1.4 MnM view
4.3.1 BIOMÉRIEUX
4.3.1.1 Business overview
4.3.1.2 Products offered
4.3.1.3 Recent developments
4.3.1.4 MnM view
4.4.1 THERMO FISHER SCIENTIFIC INC.
4.4.1.1 Business overview
4.4.1.2 Products offered
4.4.1.3 Recent developments
4.4.1.4 MnM view
4.5.1 ABBOTT LABORATORIES
4.5.1.1 Business overview
4.5.1.2 Products offered
4.5.1.3 MnM view
4.6.1 PARKER HANNIFIN CORP
4.6.1.1 Business overview
4.6.1.2 Products offered
4.7.1 SMC CORPORATION
4.7.1.1 Business overview
4.7.1.2 Products offered
4.7.1.3 Recent developments
4.8.1 IDEX CORPORATION
4.8.1.1 Business overview
4.8.1.2 Products offered
4.8.1.3 Recent developments
4.9.1 FORTIVE
4.9.1.1 Business overview
4.9.1.2 Products offered
4.10.1 PERKINELMER INC.
4.10.1.1 Business overview
4.10.1.2 Products offered
4.10.1.3 Recent developments
4.11.1 AGILENT TECHNOLOGIES, INC.
4.11.1.1 Business overview
4.11.1.2 Products offered
4.11.1.3 Recent developments
4.12.1 BIO-RAD LABORATORIES, INC.
4.12.1.1 Business overview
4.12.1.2 Products offered
4.12.1.3 Recent developments
The Microfluidics Market Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Microfluidics Market. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 40 companies of which the Top 7 Microfluidics Market Companies were categorized and recognized as the quadrant leaders.
Several key factors are fueling the growth of the microfluidics market, driving its expansion and broader applications. The rising demand for point-of-care diagnostics has created a need for fast, accurate, and cost-effective instruments. Additionally, the growing focus on personalized medicine has amplified the demand for precise biomarker analysis and high-throughput screening. Increased investment in research and development further accelerates the exploration of novel and innovative technologies, contributing significantly to market growth.
The 360 Quadrant maps the Microfluidics Market companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Microfluidics Market quadrant. The top criteria for product footprint evaluation included Type (Descriptive Analytics, Predictive Analytics and Prescriptive Analytics), Application(Research & Development, Commercial Analytics, Regulatory Compliance, Manufacturing & Supply Chain Optimization and Safety) and Component.
Key Players:
Some of the prominent players are Abbott laboratories (US) , Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD(US), Bio-Rad laboratories, Inc (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Coporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK) and Elveflow (France). These players are increasingly focusing on product launches and enhancements, investments, partnerships, collaborations, joint ventures, funding, acquisition, expansions, agreements, sales contracts, and alliances to strengthen their presence in the global market.The Full List
